Company Quick10K Filing
Provectus Biopharmaceuticals
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-05
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-07
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-23
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-13
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-14
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-14
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-06-24
8-K 2020-06-24
8-K 2019-12-31
8-K 2019-12-20
8-K 2019-06-26
8-K 2019-05-17
8-K 2019-05-08
8-K 2019-04-29
8-K 2019-03-25
8-K 2019-01-24
8-K 2018-11-26
8-K 2018-07-26
8-K 2018-06-27
8-K 2018-06-27
8-K 2018-04-19
8-K 2018-04-05
8-K 2018-02-23
8-K 2018-02-22
8-K 2018-01-25

Provectus Biopharmaceuticals Financials

PVCT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
General Cannabis (CANN) 28,438 73% -3.3 -210% 4,611 5,703 4,225 3,065 -9,663 -9,239 30,057
Investview (INVU) 28,403 95% -3.1 -74% 12,478 16,067 22,487 21,461 -9,179 -8,893 27,145
Cannabics Pharmaceuticals (CNBX) 27,044 31% 14.8 9% 19,772 454 11 3 1,794 1,794 26,551
United Cannabis (CNAB) 28,154 4% -1.6 -193% 9,051 14,945 13,098 487 -17,423 -16,727 27,588
Q Biomed (QBIO) 27,006 -4.5 -1,090% 682 5,043 0 0 -7,437 -6,777 30,497
Advanzeon (CHCR) 27,618 70% -14.6 -100% 2,742 30,704 301 210 -2,746 -2,746 40,162
Jerrick Media Holdings (JMDA) 27,492 100% -5.4 -192% 2,815 8,728 133 133 -5,404 -5,075 27,325
Target Group (CBDY) 27,351 -6.5 -20% 21,149 6,521 0 0 -4,306 -4,212 27,259
Provectus Biopharmaceuticals (PVCT) 27,200 -6.6 -343% 1,564 24,152 0 0 -5,367 -4,066 26,766
Neuroone Medical Technologies (NMTC) 27,122 -4.0 -1,273% 533 1,770 0 0 -6,781 -6,764 26,862
Peerstream (PEER) 27,093 80% -1,005.5 -2% 19,727 3,788 12,704 10,180 -484 -23 23,468
Social Life Network (WDLF) 27,065 -4% -7.4 367,804,900% 814 177 -8 -3,678 -3,677 27,048
Know Labs (KNWN) 26,998 22% -9.9 -272% 2,640 5,937 2,303 514 -7,187 -3,196 31,595
Cannabis Sativa (CBDS) 26,935 57% -15.1 -50% 4,419 2,819 813 467 -2,228 -1,770 26,713
Innovation Pharmaceuticals (IPIX) 26,737 -3.3 -190% 4,315 8,859 0 0 -8,181 -7,945 25,827
Quaint Oak Bancorp (QNTO) 26,452 3.1 1% 293,820 268,272 0 0 1,880 6,849 20,946
Cadus (KDUS) 26,288 -55.5 -1% 38,250 654 0 0 -434 -432 23,980
Crexendo (EXE) 26,258 0% 23.5 12% 7,386 3,735 13,805 0 903 974 22,854
Uniroyal Global (UNIR) 26,159 17% 6.7 2% 67,073 55,045 71,523 12,088 1,274 4,550 30,305
OvaScience (OVAS) 26,153 -46% 0.7 -59% 49,234 4,323 294 -134 -29,280 -28,277 -20,247

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash14,39010,8137,7064,9004,0721,8421,2224,3184,6368,25415,69616,64918,12617,77417,39214,17123,11718,88414,1799,7614,8915,1781,1664371,128208106244131232511,7681,324435
Accounts Receivable283282
Inventory
PP&E24222035333130282732302827969289868985827875726963858783807672696562
Assets20,46716,66913,35010,4459,4667,0116,2049,2729,37312,78020,00820,79122,09921,64826,18422,77131,24226,60420,44016,01910,82910,6865,6114,5104,9293,8523,4363,0583,5262,4221,9883,6922,7181,564
Accounts Payable37314710131318928124350652023497254804784416535199731,8871,3987731,4861,9202,7713,2743,5523,2713,6823,5002,4603,3121,4591,5541,346
Long-Term Debt
Liabilities5,6934,5023,3304,2574,6013,5871,8113,8163,0264,05713,3806,2712,1192,1089941,0759952,0754,1231,8351,6895,3762,1425,4319,14411,16113,45515,55417,22617,71119,40622,49723,68424,152
Stockholders' Equity14,77512,16610,0206,1884,8643,4244,3935,4576,3478,7236,62914,52019,98019,53925,19021,69630,24724,52916,31714,1849,1405,3103,469-920-4,215-7,309-10,019-12,496-13,700-15,289-17,417-18,804-20,965-22,588
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000000000000000
Cost of Revenue000000000000
Gross Profit000000000000
R&D2,0073,4421,8361,5651,6581,1306537417781,2977801,1581,0261,3581,5962,2812,0572,6973,6742,4082,0052,4611,6691,8542,3792,3901,5821,9439875281,0371,2081,004
SG&A3,2043,8612,3942,4722,4602,2971,4332,3382,3412,1861,8963,0562,9672,3002,6802,1722,3672,9145,8216,0993,0403,3163,5142,5459247291,3209631,576829759631438
Tax00000000
Net Income-4,535-6,443-3,452-4,468-3,833-2,347-1,921-4,170-2,377-4,553-16,598-6,667-643-3,749816-4,525-4,545-5,780-9,652-8,506-5,044-5,876-5,001-4,389-1,808-3,111-2,722-2,900-1,244-1,609-1,370-2,177-1,820
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-3,771-3,943-2,790-2,906-2,230-3,333-2,976-1,969-2,762-2,185-2,851-3,417-4,177-4,187-4,032-4,227-4,964-8,053-4,870-5,002-4,012-3,229-2,359-2,294-2,466-1,740-919-2,066-1,491-1,494
Cash Investing00-1600000-700000-60-50
Cash Financing19383602,07802,7136,0732,2876,3869,6283,8034,8943,79596612,97902593,63505,28902,5003,0501,4012,3681,8781,0213,8051,050604